The global sore throat lozenges market is estimated to be valued at USD 4.4 billion in 2024. The market is expected to expand at a CAGR rate of 5.6% and reach a valuation of ~USD 7.5 billion by 2034.
| Data Points | Market Insights |
|---|---|
| Sore Throat Lozenges Market Value, 2023 | USD 4.1 billion |
| Estimated Market Value 2024 | USD 4.4 billion |
| Projected Market Value 2034 | USD 7.5 billion |
| Valued-based CAGR (2024 to 2034) | 5.6% |
| Market Share of Top 5 Countries | 57.1% |
Around the world, the common cold and cough are very frequent. Consequently, there is a constant need for therapies and medications to treat it. This fuels the demand for throat lozenges often referred to as cough sweets, cough drops, cachous, or troches, which are small, medicinal pills that are frequently used as the first line of treatment against the common cold and flu.
The thin, moist mucosa that lines the throat is susceptible to invasion by bacteria and viruses. This causes inflammation, which manifests as redness, swelling, and increased secretions. The demand for lozenges is increasing for treatment of infection as they contain active components, such as antiseptics, painkillers, menthol, eucalyptus oil, cough suppressants like dextromethorphan, and calming substances.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The sale of sore throat lozenges market expanded at a CAGR of 4.9% during the historical period, owing to a rise in over-the-counter (OTC) medications, especially for common cold and flu remedies.
| Attribute | Details |
|---|---|
| HCAGR (2019 to 2023) | 4.9% |
The market for sore throat lozenges is expected to rise over the forecast period. This is because of the increase in demand for these decongestants due to increasing cases of nasal and throat infections, especially during seasonal changes. Children are at higher risk of acquiring infections, and they prefer these lozenges over any other second line of treatments available.
Additionally, throat lozenges are used as the initial course of treatment for sore throats, colds, and flu. Moreover, among all flu strains, the common cold is the one that individuals tend to cure at home rather than constantly seeking medical attention. This is one of the reasons for the growth of the market for sore throat lozenges. The global market for sore throat lozenges is anticipated to exhibit a CAGR of 5.6% during the forecast period.
The aging population's decreased immunity can increase the frequency of catching colds and other diseases with sore throats as a symptom. This is expected to generate opportunities in the market. More throat decongestants in the form of lozenges, which quickly relieve symptoms, are highly recommended.
Since ancient times, lozenges have been used to treat throat infections. To improve the effectiveness of the throat lozenge's activities, a small amount of heroin and morphine are also added. The newest addition to the decongestant medications for sore throat is zinc lozenges. In underdeveloped nations, zinc deficiency is common. Within 48 hours of the onset of symptoms, zinc lozenges are commonly given every 2 to 3 hours to treat the common cold.
Sore throat lozenges provide momentary or symptomatic relief to patients suffering from extreme pain caused by severe infection. Moreover, continuous advancements and new product announcements enriched with natural herbs and components are projected to support growth in the market. Accessibility is a significant aspect that can propel the market's expansion. Almost all neighborhood pharmacies and local drug stores sell these throat decongestants over the counter. Due to this, the industry is expected to grow at a profit in the upcoming years.
Principal Consultant
The sore throat lozenges market is expected to show attractive growth over the coming years. The global throat lozenges industry is quite saturated due to the presence of several local and international businesses offering wide varieties of cough and cold relief products in the market. While some organizations have implemented strategic approaches like acquisition and strategic alliance for market expansion, the majority of businesses are concentrating on affordable treatment. These throat lozenges must be taken several times during the day to provide temporary comfort.
Menthol-containing lozenges may make the situation worse rather than better, depending on how they are made. Additionally, it may occasionally trigger hypersensitivity reactions in those who are allergic to the content. It may also lead to irritable larynx syndrome. Some studies indicate that these OTC first-line drugs, which just provide symptomatic relief, may even make the situation worse; as a result, they should only be taken cautiously and when necessary.
| Country/Region | CAGR (2024 to 2034) |
|---|---|
| United Kingdom | 5.4% |
| Germany | 5.2% |
| Japan | 4.6% |
| China | 6.6% |
Due to the numerous awareness campaigns aimed at reducing infectious diseases in the area as well as the existence of several big throat lozenge manufacturers, the market is expected to grow at a CAGR of 5.4% over the forecast period. The country’s cold climate promotes the growth of bacteria that cause throat infections and also boosts the market there.
The region’s high proportion of elderly people and the effects of the cold climate drive the expansion of the market in Japan. The market in Japan is expected to grow at a CAGR of 4.6% during the forecast period.
Germany accounted for around 27.4% of Europe’s market in 2023. The market is Germany in expected to grow at a CAGR of 5.2% through 2034. Factors such increased number of top pharmaceutical manufacturers in Germany account for this high market demand in the sore throat lozenges market.
The market in China is expected to register a CAGR of 6.6% over the forecast period. The increase in the number of children and the elderly population susceptible to developing a throat infection is surging the demand for throat lozenges, propelling the market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Top Product Type | Hard Candy Lozenges |
|---|---|
| Market Share in 2024 | 46.5% |
The demand for hard candy lozenges is projected to showcase significant growth during the specified period. This segment holds a substantial share of 46.5% of the market by product. These hard candy lozenges are more common and contribute more to the market, owing to their popularity and easy availability.
| Top Type | OTC Medication |
|---|---|
| Market Share in 2024 | 85.3% |
OTC type of medication for common flu and pharyngitis is highly preferred for sore throat lozenges type and it holds a maximum share of 85.3% of the market by type. Due to their availability in the market and in all medicine stores, over-the-counter medications are highly preferred by consumers.
| Top Distribution Channel | Retail Pharmacies |
|---|---|
| Market Share in 2024 | 36.7% |
Retail Pharmacies facilitate sales of the product worth USD 1.5 billion and hold a share of 36.7% of the market by distribution channel. The easy availability of throat lozenges in the local drug stores and their OTC prescriptions drive the demand for lozenges.
The market for sore throat lozenges is characterized by the presence of experienced competitors. These companies are focused on making decongestants easily accessible to the general public in large quantities. Key strategies employed by companies in the sore throat lozenges industry include new product innovation, launches, obtaining regulatory approvals, and expanding their operations. These strategies enable them to stay competitive and meet the evolving needs of consumers.
Recent Developments
| Attribute | Details |
|---|---|
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | USD billion for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, Russia, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, Israel, North Africa, and South Africa |
| Key Market Segments Covered | Product, Type, Distribution Channel, and Region |
| Key Companies Profiled | iNova Pharmaceuticals; Procter & Gamble (P&G) Company; Reckitt Benckiser Group Plc; Ricola AG; Mondelez International.; Thornton & Ross Ltd.; Traditional Medicinals, Inc.; Bliss GVS Pharma Ltd.; GlaxoSmithKline Plc; Honibe; SSL International; Cipla Ltd; Novartis; Johnson & Johnson |
| Pricing | Available upon Request |
The sore throat lozenges market is worth USD 4.4 billion in 2024 and is set to expand 1.7X over the next ten years.
The sore throat lozenges market is expected to reach USD 7.5 billion by the end of 2034.
The global market is expected to expand at a CAGR of 5.6% through 2034 due to the rising geriatric population and increased cases of common cold and throat infections.
The United States, China, Japan, Germany, and India are the top 5 countries that are driving the demand for sore throat lozenges.
North America is one of the key markets for sore throat lozenges, with the USA accounting for about 92.7% of the North American sore throat lozenges market.
Demand for sore throat lozenges in Europe is expected to register a growth of 5.1% over the next ten years.
South Asia’s market in sore throat lozenges is offering lucrative growth opportunities and is expected to exhibit healthy growth of 6.7% CAGR during the forecast period.
iNova Pharmaceuticals, Procter & Gamble (P&G) Company, Reckitt Benckiser Group Plc, Ricola AG, and Mondelēz International., are some of the key players in the sore throat lozenges industry.
1. Executive Summary 2. Market Overview 3. Brand Mapping Analysis 4. Distribution Channel Wise Key Brand Positioning 5. Consumer Buying Behavior Analysis 6. Market Trends & Dynamics 7. Value Added Insights 8. Market Background 9. Global Market Demand (in Value or Size in USD Million) Analysis 2018 to 2023 and Forecast, 2024 to 2034 10. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Product 10.1. Hard candy lozenges 10.2. Soft lozenges 10.3. Compressed lozenges 11. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Type 11.1. OTC 11.2. Prescription 12. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Distribution Channel 12.1. Hospital 12.2. Retail Pharmacies 12.3. Drug stores 12.4. Online pharmacies 13. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region 13.1. North America 13.2. Latin America 13.3. Europe 13.4. South Asia 13.5. East Asia 13.6. Oceania 13.7. Middle East & Africa 14. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 15. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 16. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034 17. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034 18. South Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034 19. Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034 20. Middle East & Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034 21. Market Structure Analysis 22. Competition Analysis 22.1. iNova 22.2. Procter & Gamble (P&G) Company 22.3. Reckitt Benckiser Group Plc 22.4. Ricola AG 22.5. Mondelēz International 22.6. Thornton & Ross Ltd. 22.7. Traditional Medicinals, Inc. 22.8. Bliss GVS Pharma Ltd. 22.9. GlaxoSmithKline Plc 22.10. Honibe 22.11. SSL International 22.12. Cipla Ltd 22.13. Novartis 22.14. Johnson & Johnson 22.15. Other Players (As Requested) 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Food and Beverage Insights
View Reports
Sore Throat Lozenges Market
